Literature DB >> 17160405

Abnormal expressions of the subunits of the UDP-N-acetylglucosamine: lysosomal enzyme, N-acetylglucosamine-1-phosphotransferase, result in the formation of cytoplasmic vacuoles resembling those of the I-cells.

Cecilia Y S Ho1, Nelson L S Tang, Ava K Y Yeung, Abby K C Lau, Joannie Hui, Anthony W I Lo.   

Abstract

Defects in the multimeric enzyme, UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (GNPT), result in the diseases of mucolipidosis (ML). This enzyme generates the mannose 6-phosphate residues on newly synthesized lysosomal enzymes for the efficient receptor-mediated transport to lysosomes. The enzyme contains alpha/beta and gamma subunits. Mutations in the alpha/beta subunit result in the classical ML II and IIIA, while defects in the gamma subunit results in the clinically milder ML IIIC. I-cells, a distinct histological feature characterized by the presence of abnormal cytoplasmic vacuoles, are detected in many cell types, most noticeably, in ML II patients. In this study, we investigated the interactions of the alpha/beta and gamma subunits in the pathogenesis of I-cells. We noted low and deranged alpha/beta subunit expressions in human mucolipidosis cell lines. Unexpectedly, high gamma subunit expressions were also observed. In normal mouse fibroblasts, when alpha/beta subunit was suppressed, abnormal cytoplasmic vacuoles were induced, and up-regulation of the gamma subunit was also observed. On the other hand, suppressing the gamma subunit resulted in biphasic responses of the alpha/beta subunit, while abnormal cytoplasmic vacuoles were not formed, regardless of the expression levels of the alpha/beta subunit. Our data suggest reciprocal feedback mechanisms between alpha/beta and the gamma subunits. A fine balance of the expressions of these subunits may play an important role in the formation of I-cells in this group of lysosomal storage disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160405     DOI: 10.1007/s00109-006-0128-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  15 in total

1.  When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients.

Authors:  Ruth Bargal; Marsha Zeigler; Bassam Abu-Libdeh; Vivi Zuri; Hanna Mandel; Ziva Ben Neriah; Fiona Stewart; Nursel Elcioglu; Tareq Hindi; Martine Le Merrer; Gideon Bach; Annick Raas-Rothschild
Journal:  Mol Genet Metab       Date:  2006-04-21       Impact factor: 4.797

2.  The missing link in lysosomal enzyme targeting.

Authors:  W S Sly
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III.

Authors:  A Raas-Rothschild; R Bargal; O Goldman; E Ben-Asher; J E M Groener; A Toutain; E Stemmer; Z Ben-Neriah; H Flusser; F A Beemer; M Penttinen; T Olender; A J J T Rein; G Bach; M Zeigler
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

4.  Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA.

Authors:  Kyung Hoon Paik; Seng Mi Song; Chang Seok Ki; Han-Wook Yu; Jung Sim Kim; Ki Hoon Min; Soo Hee Chang; Eun Jae Yoo; In Jung Lee; Eun Kyung Kwan; Sun Joo Han; Dong-Kyu Jin
Journal:  Hum Mutat       Date:  2005-10       Impact factor: 4.878

5.  Overexpression of mouse GlcNAc-1-phosphotransferase-gamma subunit in cells induced an I-cell-like phenotype of mucolipidosis.

Authors:  Qiang Sun; Jiang Li; Chunmei Wang; Xiaofeng Huang; Hongyan Huang; Dewei Du; Yingmin Liang; Hua Han
Journal:  Gene       Date:  2005-01-27       Impact factor: 3.688

6.  Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase.

Authors:  Stephan Tiede; Stephan Storch; Torben Lübke; Bernard Henrissat; Ruth Bargal; Annick Raas-Rothschild; Thomas Braulke
Journal:  Nat Med       Date:  2005-10-02       Impact factor: 53.440

7.  Missense mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTA) in a patient with mucolipidosis II induces changes in the size and cellular distribution of GNPTG.

Authors:  Stephan Tiede; Michael Cantz; Jürgen Spranger; Thomas Braulke
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

8.  Missense mutations in N-acetylglucosamine-1-phosphotransferase alpha/beta subunit gene in a patient with mucolipidosis III and a mild clinical phenotype.

Authors:  Stephan Tiede; Nicole Muschol; Gert Reutter; Michael Cantz; Kurt Ullrich; Thomas Braulke
Journal:  Am J Med Genet A       Date:  2005-09-01       Impact factor: 2.802

9.  The alpha- and beta-subunits of the human UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase [corrected] are encoded by a single cDNA.

Authors:  Mariko Kudo; Ming Bao; Anil D'Souza; Fu Ying; Huaqin Pan; Bruce A Roe; William M Canfield
Journal:  J Biol Chem       Date:  2005-08-24       Impact factor: 5.157

10.  Mucolipidosis III is genetically heterogeneous.

Authors:  N K Honey; O T Mueller; L E Little; A L Miller; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more
  2 in total

1.  Enigmatic in vivo GlcNAc-1-phosphotransferase (GNPTG) transcript correction to wild type in two mucolipidosis III gamma siblings homozygous for nonsense mutations.

Authors:  Renata Voltolini Velho; Nataniel Floriano Ludwig; Taciane Alegra; Fernanda Sperb-Ludwig; Nicole Ruas Guarany; Ursula Matte; Ida V D Schwartz
Journal:  J Hum Genet       Date:  2016-03-03       Impact factor: 3.172

2.  A de novo or germline mutation in a family with Mucolipidosis III gamma: Implications for molecular diagnosis and genetic counseling.

Authors:  Renata Voltolini Velho; Taciane Alegra; Fernanda Sperb; Nataniel Floriano Ludwig; Maria Luiza Saraiva-Pereira; Ursula Matte; Ida V D Schwartz
Journal:  Mol Genet Metab Rep       Date:  2014-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.